About the Product

Description


Dimezeft 1GM Injection contains Ceftazidime, a third-generation cephalosporin antibiotic widely recognized for its broad-spectrum antibacterial activity. It is particularly effective against a variety of gram-negative and gram-positive bacteria, including Pseudomonas aeruginosa, making it an essential choice for treating severe and complicated bacterial infections.

This injection works by inhibiting bacterial cell wall synthesis, which leads to the death of the bacteria. It is commonly used in hospital settings to manage life-threatening infections such as pneumonia, urinary tract infections (UTIs), septicemia, intra-abdominal infections, skin and soft tissue infections, and bone and joint infections.

Dimezeft 1GM Injection is administered via intravenous or intramuscular routes under the supervision of a healthcare professional. It is a reliable solution for critically ill patients or those with compromised immunity, ensuring swift bacterial eradication and recovery. Its robust efficacy and safety profile make it a preferred choice in critical care settings.

Common side effects include nausea, diarrhea, pain or redness at the injection site, or mild allergic reactions. Severe reactions like anaphylaxis are rare but require immediate medical attention.

Used for severe bacterial infections, including pneumonia, septicemia, UTIs, and infections of the skin, bones, joints, and abdomen.

This medication should be administered only under medical supervision. Follow the prescribed dosage and complete the treatment course to prevent antibiotic resistance.

Store below 25°C, protected from light and moisture. Use reconstituted solutions promptly as advised by a healthcare provider.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions